Prestigious Prize Recognizes Pioneering Body's Defenses Discoveries

This year's prestigious award in medical science was granted for transformative discoveries that clarify how the immune system targets dangerous pathogens while sparing the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the organism.

These findings are now enabling innovative therapies for immune disorders and malignancies.

These winners will share a monetary award worth 11 million Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the body's defenses functions and the reason we don't all suffer from severe self-attack conditions," stated the chair of the award panel.

This trio's research explain a fundamental mystery: In what way does the immune system protect us from numerous infections while keeping our healthy cells unharmed?

The immune system employs white blood cells that search for signs of disease, even pathogens and bacteria it has not met before.

Such defenders employ detectors—called recognition units—that are generated randomly in a vast number of combinations.

This gives the defense network the ability to combat a broad range of threats, but the unpredictability of the mechanism inevitably creates immune cells that can target the body.

Protectors of the Body

Scientists previously knew that some of these harmful defense cells were destroyed in the thymus—where immune cells develop.

This year's award honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that assault the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The discoveries have established a novel area of research and spurred the development of new treatments, for instance for tumors and autoimmune diseases."

Regarding cancer, regulatory T-cells block the system from fighting the tumor, so studies are aimed at reducing their quantity.

In autoimmune diseases, trials are testing increasing T-reg cells so the organism is not under attack. A comparable method could also be useful in reducing the risks of transplanted organ rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from a Japanese institution, conducted tests on rodents that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that injecting immune cells from other animals could prevent the disease—implying there was a system for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in mice and humans that resulted in the identification of a genetic factor vital for the way regulatory T-cells operate.

"Their groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a prominent biological science specialist.

"This work is a striking illustration of how fundamental biological research can have far-reaching consequences for public health."